Scott Gottlieb

Scott Gottlieb joins Pfizer's board

Scott Gottlieb speaks at a public event.
Scott Gottlieb is getting closer to the industry he regulated. Photo: Chuck Kennedy for Axios

Pfizer, which has clashed with President Trump over drug prices, has appointed former FDA commissioner Scott Gottlieb to its board of directors. The role pays $335,000 annually in cash and stock.

The big picture: Since leaving the Trump administration roughly 3 months ago, Gottlieb has rejoined a conservative think tank and a venture capital firm that has pharmaceutical investments. Cycling between public office and well-paying private sector companies has become commonplace among FDA officials as well as other top health agency leaders.

The rise of unproven billion-dollar health care industries

Former FDA commissioner Scott Gottlieb. Photo: Astrid Riecken For The Washington Post via Getty Images
Former FDA commissioner Scott Gottlieb. Photo: Astrid Riecken For The Washington Post via Getty Images

The FDA has its work cut out for it as it tries to rein in unregulated and unproven industries that are racking up public attention and billion-dollar profits.

Why it matters: "I think the FDA is taking on industries where there is a potent political constituency trying to resist regulation. And that's hard," former FDA commissioner Scott Gottlieb said.